The weight-loss drug boom is creating a whirlwind of uncertainty for the fitness industry around a very basic question: Will GLP-1 users work out more or less?
Why it matters: About 1 in 8 U.S. adults have already taken the medications, whether for diabetes or weight loss purposes, according to the KFF Health Tracking Poll in May 2024 — and it's expected to keep surging.
